Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen, sympathetic nervous system, and bone remodeling in postmenopausal women
NL-OMON36023Active, not recruiting
- Sponsor
- Academic Medical Center
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of estradiol, dydrogesterone, salbutamol and propranolol in osteoporosis (4 arms), sponsored by Academic Medical Center. Primary endpoints: Change in serum procollagen type I N propeptide and Change in serum C-terminal telopeptide of type I collagen. Started May 2011; status: active, not recruiting.
02
Drugs
estradioldydrogesteronesalbutamolpropranolol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NL-OMON36023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36023.